141 related articles for article (PubMed ID: 30673117)
1. Liquid biopsy in tissue-born lymphomas.
Spina V; Rossi D
Swiss Med Wkly; 2019 Jan; 149():w14709. PubMed ID: 30673117
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor DNA: clinical roles in diffuse large B cell lymphoma.
Wu FT; Lu L; Xu W; Li JY
Ann Hematol; 2019 Feb; 98(2):255-269. PubMed ID: 30368587
[TBL] [Abstract][Full Text] [Related]
3. Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas.
Kwok M; Wu SP; Mo C; Summers T; Roschewski M
Curr Treat Options Oncol; 2016 Sep; 17(9):47. PubMed ID: 27461036
[TBL] [Abstract][Full Text] [Related]
4. Minimal Residual Disease Assessment in Lymphoma: Methods and Applications.
Herrera AF; Armand P
J Clin Oncol; 2017 Dec; 35(34):3877-3887. PubMed ID: 28933999
[TBL] [Abstract][Full Text] [Related]
5. Stance of MRD in Non-Hodgkin's Lymphoma and its upsurge in the novel era of cell-free DNA.
Garg S; Kumar A; Gupta R
Clin Transl Oncol; 2021 Nov; 23(11):2206-2219. PubMed ID: 33991328
[TBL] [Abstract][Full Text] [Related]
6. The value of liquid biopsy in diagnosis and monitoring of diffuse large b-cell lymphoma: recent developments and future potential.
Camus V; Jardin F; Tilly H
Expert Rev Mol Diagn; 2017 Jun; 17(6):557-566. PubMed ID: 28415895
[TBL] [Abstract][Full Text] [Related]
7. Minimal residual disease in non-Hodgkin lymphoma - current applications and future directions.
Chase ML; Armand P
Br J Haematol; 2018 Jan; 180(2):177-188. PubMed ID: 29076131
[TBL] [Abstract][Full Text] [Related]
8. Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?
Cherng HJ; Herrera A
Curr Treat Options Oncol; 2024 May; 25(5):659-678. PubMed ID: 38656685
[TBL] [Abstract][Full Text] [Related]
9. cfDNA-Based NGS IG Analysis in Lymphoma.
Pott C; Kotrova M; Darzentas N; Brüggemann M; Khouja M;
Methods Mol Biol; 2022; 2453():101-117. PubMed ID: 35622323
[TBL] [Abstract][Full Text] [Related]
10. The Emerging Role of Minimal Residual Disease Testing in Diffuse Large B-Cell Lymphoma.
Hu R; Winter A; Hill BT
Curr Oncol Rep; 2019 Apr; 21(5):44. PubMed ID: 30941515
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy for the identification of intravascular large B-cell lymphoma.
Suehara Y; Sakata-Yanagimoto M; Hattori K; Nanmoku T; Itoh T; Kaji D; Yamamoto G; Abe Y; Narita K; Takeuchi M; Matsue K; Sato T; Noguchi M; Baba N; Sakamoto T; Kusakabe M; Kurita N; Kato T; Yokoyama Y; Nishikii H; Obara N; Hasegawa Y; Chiba S
Haematologica; 2018 Jun; 103(6):e241-e244. PubMed ID: 29472348
[No Abstract] [Full Text] [Related]
12. Exosomes and extracellular vesicles as liquid biopsy biomarkers in diffuse large B-cell lymphoma: Current state of the art and unmet clinical needs.
Ofori K; Bhagat G; Rai AJ
Br J Clin Pharmacol; 2021 Feb; 87(2):284-294. PubMed ID: 33080045
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of liquid biopsy technology in clinical practice of malignant lymphoma].
Tomita A
Rinsho Ketsueki; 2023; 64(9):1053-1065. PubMed ID: 37899183
[TBL] [Abstract][Full Text] [Related]
14. [Mediastinal large B-cell lymphoma].
Artemieva AS; Semiglazova TY; Frank GA
Vopr Onkol; 2015; 61(2):280-8. PubMed ID: 26087612
[TBL] [Abstract][Full Text] [Related]
15. Deep sequencing reveals lack of a clonal relationship between a metachronous classical hodgkin and diffuse large B-cell lymphoma.
Siddiqi IN; Ailawadhi S; Huang Q; Shibata RK; Kang H; Shibata D
Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):e87-93. PubMed ID: 24548610
[No Abstract] [Full Text] [Related]
16. Relationship between classic Hodgkin lymphoma and overlapping large cell lymphoma investigated by comparative expressed sequence hybridization expression profiling.
Vanhentenrijk V; Vanden Bempt I; Dierickx D; Verhoef G; Wlodarska I; De Wolf-Peeters C
J Pathol; 2006 Oct; 210(2):155-62. PubMed ID: 16874743
[TBL] [Abstract][Full Text] [Related]
17. Measurable Residual Disease Monitoring in Lymphoma.
Cuzzo B; Lipsky A; Cherng HJ
Curr Hematol Malig Rep; 2023 Dec; 18(6):292-304. PubMed ID: 37930608
[TBL] [Abstract][Full Text] [Related]
18. Minimal residual disease detection by flow cytometry and PARR in lymph node, peripheral blood and bone marrow, following treatment of dogs with diffuse large B-cell lymphoma.
Aresu L; Aricò A; Ferraresso S; Martini V; Comazzi S; Riondato F; Giantin M; Dacasto M; Guadagnin E; Frayssinet P; Rouquet N; Drigo M; Marconato L
Vet J; 2014 May; 200(2):318-24. PubMed ID: 24698669
[TBL] [Abstract][Full Text] [Related]
19. Plasma microRNA profiling: Exploring better biomarkers for lymphoma surveillance.
Khare D; Goldschmidt N; Bardugo A; Gur-Wahnon D; Ben-Dov IZ; Avni B
PLoS One; 2017; 12(11):e0187722. PubMed ID: 29131834
[TBL] [Abstract][Full Text] [Related]
20. The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection.
Arcaini L; Rossi D; Lucioni M; Nicola M; Bruscaggin A; Fiaccadori V; Riboni R; Ramponi A; Ferretti VV; Cresta S; Casaluci GM; Bonfichi M; Gotti M; Merli M; Maffi A; Arra M; Varettoni M; Rattotti S; Morello L; Guerrera ML; Sciarra R; Gaidano G; Cazzola M; Paulli M
Haematologica; 2015 Feb; 100(2):246-52. PubMed ID: 25381127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
